Xenetic Biosciences is trading at $2.09, up 5.31%, after closing at $1.98 on October 21; no clear company-specific announcement was identified for the move. - The latest company news located was an October 15 clinical-study update, not a new catalyst for this after-hours move. - The Nasdaq rose 1.07% and the S&P 500 gained 0.56%; this may have supported sentiment, but there is no evidence confirming it caused the stock’s move.